These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 10454092)
1. Matrix metalloproteinase-2 and -9 are activated in joint diseases. Clegg PD; Carter SD Equine Vet J; 1999 Jul; 31(4):324-30. PubMed ID: 10454092 [TBL] [Abstract][Full Text] [Related]
2. Characterisation of equine matrix metalloproteinase 2 and 9; and identification of the cellular sources of these enzymes in joints. Clegg PD; Burke RM; Coughlan AR; Riggs CM; Carter SD Equine Vet J; 1997 Sep; 29(5):335-42. PubMed ID: 9306058 [TBL] [Abstract][Full Text] [Related]
3. Recombinant equine interleukin-1beta induces putative mediators of articular cartilage degradation in equine chondrocytes. Tung JT; Fenton JI; Arnold C; Alexander L; Yuzbasiyan-Gurkan V; Venta PJ; Peters TL; Orth MW; Richardson DW; Caron JP Can J Vet Res; 2002 Jan; 66(1):19-25. PubMed ID: 11858644 [TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinases 2 and 9 in equine synovial fluids. Clegg PD; Coughlan AR; Riggs CM; Carter SD Equine Vet J; 1997 Sep; 29(5):343-8. PubMed ID: 9306059 [TBL] [Abstract][Full Text] [Related]
5. Synovial fluid gelatinase concentrations and matrix metalloproteinase and cytokine expression in naturally occurring joint disease in horses. Trumble TN; Trotter GW; Oxford JR; McIlwraith CW; Cammarata S; Goodnight JL; Billinghurst RC; Frisbie DD Am J Vet Res; 2001 Sep; 62(9):1467-77. PubMed ID: 11560279 [TBL] [Abstract][Full Text] [Related]
6. Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion. Woolley DE; Tetlow LC Arthritis Res; 2000; 2(1):65-74. PubMed ID: 11219391 [TBL] [Abstract][Full Text] [Related]
7. Determination of MMP-2 and -9 activities in synovial fluid of horses with osteoarthritic and arthritic joint diseases using gelatin zymography and immunocapture activity assays. Fietz S; Einspanier R; Hoppner S; Hertsch B; Bondzio A Equine Vet J; 2008 May; 40(3):266-71. PubMed ID: 18089467 [TBL] [Abstract][Full Text] [Related]
8. The effects of 1 alpha,25-dihydroxyvitamin D(3) on matrix metalloproteinase and prostaglandin E(2) production by cells of the rheumatoid lesion. Tetlow LC; Woolley DE Arthritis Res; 1999; 1(1):63-70. PubMed ID: 11056661 [TBL] [Abstract][Full Text] [Related]
9. Equine TIMP-1 and TIMP-2: identification, activity and cellular sources. Clegg PD; Coughlan AR; Carter SD Equine Vet J; 1998 Sep; 30(5):416-23. PubMed ID: 9758100 [TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage: associations with degenerative changes. Tetlow LC; Adlam DJ; Woolley DE Arthritis Rheum; 2001 Mar; 44(3):585-94. PubMed ID: 11263773 [TBL] [Abstract][Full Text] [Related]
11. The effect of drugs commonly used in the treatment of equine articular disorders on the activity of equine matrix metalloproteinase-2 and 9. Clegg PD; Jones MD; Carter SD J Vet Pharmacol Ther; 1998 Oct; 21(5):406-13. PubMed ID: 9811443 [TBL] [Abstract][Full Text] [Related]
12. Interleukin-1 stimulation of equine articular cells. May SA; Hooke RE; Lees P Res Vet Sci; 1992 May; 52(3):342-8. PubMed ID: 1620968 [TBL] [Abstract][Full Text] [Related]
13. Concentration-dependent effects of tiludronate on equine articular cartilage explants incubated with and without interleukin-1β. Duesterdieck-Zellmer KF; Driscoll N; Ott JF Am J Vet Res; 2012 Oct; 73(10):1530-9. PubMed ID: 23013178 [TBL] [Abstract][Full Text] [Related]
14. Batimastat (BB-94) inhibits matrix metalloproteinases of equine laminitis. Pollitt CC; Pass MA; Pollitt S Equine Vet J Suppl; 1998 Sep; (26):119-24. PubMed ID: 9932102 [TBL] [Abstract][Full Text] [Related]
15. Effects of glucosamine and chondroitin sulfate on mediators of osteoarthritis in cultured equine chondrocytes stimulated by use of recombinant equine interleukin-1beta. Neil KM; Orth MW; Coussens PM; Chan PS; Caron JP Am J Vet Res; 2005 Nov; 66(11):1861-9. PubMed ID: 16334941 [TBL] [Abstract][Full Text] [Related]
16. Pro-MMP-9 is a specific macrophage product and is activated by osteoarthritic chondrocytes via MMP-3 or a MT1-MMP/MMP-13 cascade. Dreier R; Grässel S; Fuchs S; Schaumburger J; Bruckner P Exp Cell Res; 2004 Jul; 297(2):303-12. PubMed ID: 15212936 [TBL] [Abstract][Full Text] [Related]
17. Activation of matrix metalloproteinases 2, 9, and 13 by activated protein C in human osteoarthritic cartilage chondrocytes. Jackson MT; Moradi B; Smith MM; Jackson CJ; Little CB Arthritis Rheumatol; 2014 Jun; 66(6):1525-36. PubMed ID: 24574263 [TBL] [Abstract][Full Text] [Related]
18. Hemoglobin stimulates the expression of matrix metalloproteinases, MMP-2 and MMP-9 by synovial cells: a possible cause of joint damage after intra-articular hemorrhage. Tajima T; Yoshida E; Yamashita A; Ohmura S; Tomitaka Y; Sugiki M; Asada Y; Maruyama M J Orthop Res; 2005 Jul; 23(4):891-8. PubMed ID: 16023005 [TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinase 10 promotion of collagenolysis via procollagenase activation: implications for cartilage degradation in arthritis. Barksby HE; Milner JM; Patterson AM; Peake NJ; Hui W; Robson T; Lakey R; Middleton J; Cawston TE; Richards CD; Rowan AD Arthritis Rheum; 2006 Oct; 54(10):3244-53. PubMed ID: 17009259 [TBL] [Abstract][Full Text] [Related]
20. Expression of membrane-type 1 matrix metalloproteinase and activation of progelatinase A in human osteoarthritic cartilage. Imai K; Ohta S; Matsumoto T; Fujimoto N; Sato H; Seiki M; Okada Y Am J Pathol; 1997 Jul; 151(1):245-56. PubMed ID: 9212749 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]